![]() ![]() We think you’d find it appealing for all the same reasons they do, with all of its leading technological trappings, which now include Apple iOS and Android app for FreeStyle Libre 2 users in the U.S. It's a better appliance for a modern world that we're working hard to continually improve, from FreeStyle Libre 14 day to FreeStyle Libre 2 to FreeStyle Libre 3, 9 which initial users are raving about.Īpproximately 3.5 million users 10 around the world count on the FreeStyle Libre system to help them managing their diabetes. These developments have included long wear times up to 14 days for each sensor, optional alarms, 5 unsurpassed 14-day accuracy 6 as well as FreeStyle LibreLink 7 and Libre LinkUp 8 apps to help those caring for people managing their diabetes to know what’s happening. It's as essential as it is inconspicuous.Įver since FreeStyle Libre's initial launch, we have kept working to make the world's leading glucose monitoring system 4 - an appellation we do not take for granted - even better. With its small sensor size - its appearance likely to go unnoticed - FreeStyle Libre 2 app users can discreetly 3 check their glucose with a quick, 1-second scan of their compatible phone over their sensor. And with these apps, you're likely to have an easier time staying in range. Simply apply the sensor to the back of your upper arm and with your app, scan the sensor to get your latest glucose value, including a trend arrow and 8-hour historical graph showing how your glucose is reacting to food, exercise and more.įor those still checking their glucose with routine fingersticks, 2 it's hard to fathom how FreeStyle Libre technology could disappoint. Whatever apprehensiveness there might have been before, one important outcome of the COVID-19 pandemic has been a near insatiable appetite for more reliable digital and connected diabetes care.Īnd that's just what these FreeStyle Libre 2 apps bring. We appreciate the readily apparent need for these kinds of applications of technology to daily lives. We understand the appeal to connected care and the rapport many have with their smart devices. Review all product information before use or contact Abbott Toll Free (85) or visit for detailed indications for use and safety information.In the spirit of keeping you apprised of the latest updates to our diabetes monitoring apparatus - you know, FreeStyle Libre 2, an integrated continuous glucose monitoring (iCGM) system - the Food and Drug Administration has cleared our FreeStyle Libre 2 apps for iPhone and Android users to connect their compatible 1 smartphones to their FreeStyle Libre 2 sensors. When using FreeStyle LibreLink app, access to a blood glucose monitoring system is required as the app does not provide one. The built-in blood glucose meter is not for use on dehydrated, hypotensive, in shock, hyperglycemic-hyperosmolar state, with or without ketosis, neonates, critically-ill patients, or for diagnosis or screening of diabetes. Sensor placement is not approved for sites other than the back of the arm and standard precautions for transmission of blood borne pathogens should be taken. The systems are not approved for pregnant women, persons on dialysis, or critically-ill population. The systems do not have alarms unless the sensor is scanned, and the systems contain small parts that may be dangerous if swallowed. Check sensor glucose readings with a blood glucose meter when Check Blood Glucose symbol appears, when symptoms do not match system readings, or when readings are suspected to be inaccurate. ![]() Remove the sensor before MRI, CT scan, X-ray, or diathermy treatment.ĭo not ignore symptoms that may be due to low or high blood glucose, hypoglycemic unawareness, or dehydration. The systems are intended for single patient use and require a prescription. FreeStyle Libre and FreeStyle Libre 14 day Flash Glucose Monitoring systems are continuous glucose monitoring (CGM) devices indicated for replacing blood glucose testing and detecting trends and tracking patterns aiding in the detection of episodes of hyperglycemia and hypoglycemia, facilitating both acute and long-term therapy adjustments in persons (age 18 and older) with diabetes.
0 Comments
Leave a Reply. |